MDPI and ACS Style
Blinova, E.; Enikeev, D.; Roshchin, D.; Samyshina, E.; Deryabina, O.; Tertychnyy, A.; Blinov, D.; Kogan, E.; Dudina, M.; Barakat, H.;
et al. Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy. Cancers 2020, 12, 1316.
https://doi.org/10.3390/cancers12051316
AMA Style
Blinova E, Enikeev D, Roshchin D, Samyshina E, Deryabina O, Tertychnyy A, Blinov D, Kogan E, Dudina M, Barakat H,
et al. Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy. Cancers. 2020; 12(5):1316.
https://doi.org/10.3390/cancers12051316
Chicago/Turabian Style
Blinova, Ekaterina, Dmitry Enikeev, Dmitry Roshchin, Elena Samyshina, Olga Deryabina, Aleksander Tertychnyy, Dmitry Blinov, Evgenia Kogan, Marina Dudina, Haydar Barakat,
and et al. 2020. "Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy" Cancers 12, no. 5: 1316.
https://doi.org/10.3390/cancers12051316